How important is palliative care?

Current Oncology Reports

Volumn 13, Issue 4, 2011, Pages 252-254

  Jatoi, Aminah ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGGRESSION; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DEPRESSION; DRUG EFFICACY; EARLY INTERVENTION; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; METASTASIS; PATIENT ASSESSMENT; PATIENT COUNSELING; QUALITY OF LIFE; TERMINAL CARE; TOTAL QUALITY MANAGEMENT;

EID: 80051669070     PISSN: 15233790     EISSN: 15346269     Source Type: Journal    
DOI: 10.1007/s11912-011-0168-x     Document Type: Article

References (5)

1. SR Connor B Pyenson K Fitch C Spence K Iwasaki 2007 Comparing hospice and nonhospice patient survival among patients who die within a three-year window J Pain Symptom Manage 33 238 46 17349493 10.1016/j.jpainsymman.2006.10.010 (Pubitemid 46349540)
2. A Sandler R Gray MC Perry, et al. 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer N Engl J Med 355 2542 50 17167137 10.1056/NEJMoa061884 1:CAS:528:DC%2BD28XhtlWqsbzI (Pubitemid 44917502)
3. R Pirker JR Pereira A Szczesna, et al. 2009 Cetuximab plus chemotherapy in patients with advanced non-small cell lung cancer (FLEX): an open-label randomized phase III trial Lancet 373 1525 31 19410716 10.1016/S0140-6736(09) 60569-9 1:CAS:528:DC%2BD1MXltlaqurs%3D
4. http://www.medscape.com/viewarticle/727136 ; last accessed February 22, 2011.
5. http://doctorrw.blogspot.com/2010/09/palliative-care-may-prolong- survival.html ; last accessed February 22, 2011.